Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02971137 · ClinicalTrials.gov registry record · NA
Pain and Smoking Study
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 371
- Enrollment target
NCT02971137: Completed NA study, sponsored by VA Office of Research and Development.
NCT02971137 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 371 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02971137, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 371 participants
- Enrollment target
Study Summary
This purpose of this study is to test the telephone delivery of a cognitive behavioral intervention (CBI), for smoking cessation among Veteran smokers with chronic pain
Primary Outcome
In the past 6 months, have he/she smoked any in each of 2 consecutive weeks?
Interventions
- BEHAVIORAL Smoking Cessation plus CBI
- BEHAVIORAL Smoking Cessation Standard
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 371 participants |
| Start Date | 2017-12-22 |
| Est. Completion | 2022-01-31 |
| Phase | NA |
What the finished NCT02971137 record still lists
NCT02971137 is an interventional study that assigns participants to a tested intervention. The registered 371 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 2 interventions - of which Smoking Cessation plus CBI is the first listed.
NCT02971137 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02971137 about?
NCT02971137 is a clinical study titled "Pain and Smoking Study". This purpose of this study is to test the telephone delivery of a cognitive behavioral intervention (CBI), for smoking cessation among Veteran smokers with chronic pain
What is the current status of trial NCT02971137?
This trial is currently completed. It is a NA study. The enrollment target is 371 participants. The study started on 2017-12-22. Estimated completion is 2022-01-31.
What interventions are being tested in trial NCT02971137?
The interventions under investigation include: Smoking Cessation plus CBI (BEHAVIORAL), Smoking Cessation Standard (BEHAVIORAL).
Who is sponsoring clinical trial NCT02971137?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02971137's enrollment target sits among peer trials
371 281st of 2000 higher than 1,720 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05743673 · 371 participants
SHAPE Test for Preoperative Risk Stratification
- NCT05761847 · 371 participants · NA
Pediatric Medication Therapy Management Trial
- NCT04801589 · 372 participants · Phase 3
Goal-Directed Sedation in Mechanically Ventilated Infants and Children
- NCT04879329 · 372 participants · Phase 2
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI